- Issuer ticker
-
SPRO
- Reported as of
-
10 Nov 2026
- Net transaction value
-
$0
Source evidence
Original filing metadata and source links for verification.
4 source fields
- SEC form
-
4
- Accepted by SEC
-
10 Nov 2026, 18:26:26 UTC
Reporting owner
1 detail
- Reporting owner signature
-
/s/ Maegan Deare, Attorney-in-Fact for William Ho
Filing notes and source
Key filing fact
William Ho filed Form 4 for Spero Therapeutics, Inc. (SPRO) on 10 Nov 2026.
Key facts
- This page summarizes William Ho's Form 4 filing for Spero Therapeutics, Inc. (SPRO).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 10 Nov 2026, 18:26.
Change
- Previous filing in this sequence was filed on 24 Jun 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0001400901
Primary reporting owner
HO WILLIAM
- Relationship
-
Director
- Address
- C/O 675 MASSACHUSETTS AVENUE, 14TH FLOOR, CAMBRIDGE
- Signature
- /s/ Maegan Deare, Attorney-in-Fact for William Ho
- Signature date
- 10 Nov 2026
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
SPRO
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- Shares
- +100,000
- Change %
- Price
-
$0.000000*
- Shares after
- 100,000
- Date
- 10 Nov 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 100,000
- Exercise price
- $1.01
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Explanation of responses
1 footnote